NEW YORK (GenomeWeb News) – Bayer CropScience said today it has inked two agreements with Cellectis plant sciences that extend a partnership focused on modifying and editing plant genes and genomes to improve crops.

Under the agreements, the partners will use tools Cellectis developed to create commercial traits for the canola seed market, and Bayer will have access to Cellectis' technologies for gene stacking and targeted mutagenesis that enable it to engineer plant genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.